Supplementary Table 1 from Breast Cancer Risk Modification in Women with Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2, and PALB2
Fields of Study & Subjects
BRCA gene mutations in cancer
Multiple and Secondary Primary Cancers
PARP inhibition in cancer therapy
Publication details
- Publication date
- 16 March 2026
- Language
- EN